HLA-A11.1/B2M(2)
品系全名
C57BL/6Smoc-B2mtm1(hB2M-linker-HLA-A*1101/H2-D1)Smoc
目录号
NM-HU-241354
品系状态
活体
基因信息
基因名
B2M
品系描述
验证数据

Fig.1 Expression analysis of hB2M and HLA-ABC on CD45+ cells in blood of HLA-A11.1/B2M humanized mice.
Leukocytes were collected from wild-type C57BL/6 mice(11 weeks old) and homozygous HLA-A11.1/B2M humanized mice(15.7 weeks old) , and analyzed by flow cytometry with anti-mB2M, anti-hB2M, anti-mH2D and anti-HLA-ABC. hB2M and HLA-ABC were exclusively detectable in HLA-A11.1/B2M humanized mice, whereas mB2M and mH2D were exclusively detectable in wild-type C57BL/6 mice.

Fig.2 Analysis of immune cell subpopulations in the blood (n=3 per group).
Leukocytes were collected from the blood of wild-type C57BL/6 mice (female, 8 weeks old; male, 9 weeks) and homozygous HLA-A11.1/B2M humanized mice (9 weeks old), and Flow cytometry analysis was performed to assess leukocyte subpopulations.
Abbr. WT, wild type; HO, homozygous.

Fig.3 Analysis of immune cell subpopulations in the spleen (n=3 per group).
Leukocytes were collected from the spleens of wild-type C57BL/6 mice (female, 8 weeks old; male, 9 weeks) and homozygous HLA-A11.1/B2M humanized mice (9 weeks old), and flow cytometry analysis was performed to assess leukocyte subpopulations.
Abbr. WT, wild type; HO, homozygous.
你也可能感兴趣
Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。
查看
